Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 10Breast 4Gastrointestinal 3Thoracic 2Sarcoma 2Lymphoid 2Gynecologic 2Genitourinary 2Dermatologic 2

Conditions

Ovarian Neoplasms 15Uterine Cervical Neoplasms 12Carcinoma, Non-Small-Cell Lung 10Melanoma 9Triple Negative Breast Neoplasms 7Endometrial Neoplasms 7Stomach Neoplasms 6Carcinoma, Transitional Cell 6Carcinoma, Renal Cell 6Squamous Cell Carcinoma of Head and Neck 5Small Cell Lung Carcinoma 5Fallopian Tube Neoplasms 5Colorectal Neoplasms 4Carcinoma, Merkel Cell 4Carcinoma, Hepatocellular 4Neoplasm Metastasis 3Mesothelioma 3Esophageal Neoplasms 3Cholangiocarcinoma 3Vulvar Neoplasms 2Urinary Bladder Neoplasms 2Seminoma 2Sarcoma 2Prostatic Neoplasms 2Pancreatic Neoplasms 2Neoplasms 2Nasopharyngeal Carcinoma 2Lung Neoplasms 2Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2Leukemia, Myeloid, Acute 2

Interventions

pembrolizumab 18Cyclophosphamide 9fludarabine 8Nivolumab 8cemiplimab 5Carboplatin 5atezolizumab 4Gemcitabine 4Filgrastim 4Drug Therapy 4Docetaxel 4Cisplatin 4palbociclib 3durvalumab 3Paclitaxel 3Interleukin-2 3Bortezomib 3fludarabine phosphate 2epacadostat 2belinostat 2avelumab 2amminedichloro(2-methylpyridine)platinum(II) 2aldesleukin 2Tobacco Use Cessation Devices 2Temozolomide 2SS1(dsFv)PE38 2Riluzole 2Peripheral Blood Stem Cell Transplantation 2Oncolytic Virotherapy 2Ipilimumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Head and Neck Neoplasms × Ipilimumab × Gynecologic × Clear all
NCT04954599 2025-10-07

Phase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICI

Maastricht University Medical Center

Phase 1/2 Recruiting
126 enrolled
BreastGastrointestinalGenitourinaryGynecologicHead & Neck

Head and Neck Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Triple Negative Breast Neoplasms

NCT03752398 2024-07-05

DUET-3

Xencor, Inc.

Phase 1 Completed
198 enrolled
BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckSarcomaThoracic

Squamous Cell Carcinoma of Head and Neck, Nasopharyngeal Carcinoma, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms, Melanoma, Pancreatic Neoplasms, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Histiocytoma, Malignant Fibrous, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡